Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Impact Of Covid-19 On The Pharmaceuticals Market

The impact of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, exhibiting a CAGR of 6.1% during the forecast period of 2022-2029.

The business has shifted its attention and prioritized the coronavirus which has hampered the market enlargement. Several medical assessments and work in a variety of therapy areas were turned down; the impact of Covid-19 on the pharmaceuticals market growth was not significantly hindered by the pandemic. Conversely the development was short-term and the market recovered their swiftness by implementing various strategies and plans in the challenge of lockdown. The market growth was pushed by the treatments and immunization courses.

The rising contagious incidences and chronic disease among citizens constantly are impelling the impact of Covid-19 on the pharmaceuticals market share globally. It is expanding due to an amplified patient population in the healthcare system. The patient population requiring personalized therapies is also increasing with the rising frequency and attentiveness of chronic conditions and transmittable diseases among the population. The rising per capita healthcare expenses in emerging and developed countries boost the number of patients undergoing treatment.

The trend is growing adoption of digital technologies across various fields in the medical sector to transform healthcare services. The market led to increased adherence to decentralized clinical trials. The augmented demand for decentralized clinical trial processes, from patient selection and enrollment to studying the trial outcomes. The trials processes and automation in the events are primary pharmacy companies to increase their research and development spending and actions to develop novel drugs and therapies.

Comprehensive Analysis of Impact Of Covid-19 On The Pharmaceuticals Market

This market development effectively provides a thorough regional assessment considering the dominant supply and demand forces that influenced the COVID-19 analysis industry. The impact of Covid-19 on the pharmaceuticals market and the trade of COVID-19 analysis are rising at a higher speed in consequence of the market segmentation. These segmentations are methodically segregated by type and distribution channel. The types are drugs (viral and bacterial diseases) and vaccines (diabetes, infectious diseases, and cardiology, oncology, neurology, respiratory, hypertension, and others). The distribution channels involve hospital, retail, and online pharmacies.

The North American region is conducive to the global impact of Covid-19 on the pharmaceuticals market, leading to a recall of USD 610.29 billion because of the progression in medical trials and presence of drug manufacturing in this region are supporting the market expansion.

The top players in the market play a crucial role in the COVID-19 analysis industry assuring industrial prospectus growth and setting market standards. These players include Sanofi (France), GSK plc. (U.K.), Johnson & Johnson Services Inc. (U.S.), Merck & Co., Inc. (U.S.), Novo Nordisk A/S (Denmark), Pfizer Inc. (U.S.), AstraZeneca (U.K.), and F. Hoffmann-La Roche Ltd. (Switzerland) are also major companies, these market players present a level-playing competitive landscape.

In June 2022, the U.S. FDA permitted Merck’s innovative immunizer, the VAXNEUVANCE. For, the insidious pneumococcal disease occurred in infants and children this vaccination is very useful for prevention.

Segmentation Table

Global Impact Of Covid-19 On The Pharmaceuticals Market Scope

ATTRIBUTE DETAILS

Study Period 2018-2029

Base Year 2021

Estimated Year 2022

Forecast Period 2022-2029

Historical Period 2018-2020

Unit Value (USD billion)

Segmentation Estimated Year

By Type Drugs

Oncology

Diabetes

Infectious Diseases

Cardiology

Neurology

Respiratory

Hypertension

Others

Vaccines

Viral Diseases

Bacterial Diseases

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region North America (U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

Latin America (Brazil, Mexico, Rest of Latin America)

Middle East & Africa (GCC, South Africa, and the Rest of Middle East & Africa)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Impact of COVID-19 on the Supply Chain
4.2. Key Industry Developments – In Response to the COVID-19 Impact
4.3. Key Regulatory and Reimbursement Changes
4.4. Disruption of R&D projects in the Pharmaceuticals space with examples for major products/companies
4.5. Shift of R&D focus form other projects to COVID-19 the Pharmaceuticals space with examples for major products/companies
4.6. Impact of COVID-19 on the overall R&D and development of new products in the healthcare market
5. Key Insights – Pharmaceuticals Market (General)
5.1. Clinical Trials in Pharmaceuticals Market - Number of Trials, Size of the Industry, Number of Participants, Number of Sites, R&D Spending of Major Companies, Economic Impact of Clinical Trials
5.2. Success Rate of Drugs - Average Time and Price to Get a Drug on the Market, Proportion of Drugs that are Successful and Reach Blockbuster Status
5.3. Risk & Opportunities in Development of New Drugs – Qualitative Insights
6. Global Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Drugs
6.1.1.1. Oncology
6.1.1.2. Diabetes
6.1.1.3. Infectious Diseases
6.1.1.4. Cardiology
6.1.1.5. Neurology
6.1.1.6. Respiratory
6.1.1.7. Hypertension
6.1.1.8. Others
6.1.2. Vaccines
6.1.2.1. Viral Diseases
6.1.2.2. Bacterial Diseases
6.2. Market Analysis, Insights and Forecast – By Distribution Channel
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
6.3. Market Analysis, Insights and Forecast – By Geography
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East & Africa
7. North America Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Drugs
7.1.1.1. Oncology
7.1.1.2. Diabetes
7.1.1.3. Infectious Diseases
7.1.1.4. Cardiology
7.1.1.5. Neurology
7.1.1.6. Respiratory
7.1.1.7. Hypertension
7.1.1.8. Others
7.1.2. Vaccines
7.1.2.1. Viral Diseases
7.1.2.2. Bacterial Diseases
7.2. Market Analysis, Insights and Forecast – By Distribution Channel
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
7.3. Market Analysis, Insights and Forecast – By Country
7.3.1. U.S.
7.3.2. Canada
8. Europe Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Drugs
8.1.1.1. Oncology
8.1.1.2. Diabetes
8.1.1.3. Infectious Diseases
8.1.1.4. Cardiology
8.1.1.5. Neurology
8.1.1.6. Respiratory
8.1.1.7. Hypertension
8.1.1.8. Others
8.1.2. Vaccines
8.1.2.1. Viral Diseases
8.1.2.2. Bacterial Diseases
8.2. Market Analysis, Insights and Forecast – By Distribution Channel
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
9. Asia Pacific Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Drugs
9.1.1.1. Oncology
9.1.1.2. Diabetes
9.1.1.3. Infectious Diseases
9.1.1.4. Cardiology
9.1.1.5. Neurology
9.1.1.6. Respiratory
9.1.1.7. Hypertension
9.1.1.8. Others
9.1.2. Vaccines
9.1.2.1. Viral Diseases
9.1.2.2. Bacterial Diseases
9.2. Market Analysis, Insights and Forecast – By Distribution Channel
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.3.1. Japan
9.3.2. China
9.3.3. India
9.3.4. Australia
9.3.5. South East Asia
9.3.6. Rest of Asia Pacific
10. Latin America Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Drugs
10.1.1.1. Oncology
10.1.1.2. Diabetes
10.1.1.3. Infectious Diseases
10.1.1.4. Cardiology
10.1.1.5. Neurology
10.1.1.6. Respiratory
10.1.1.7. Hypertension
10.1.1.8. Others
10.1.2. Vaccines
10.1.2.1. Viral Diseases
10.1.2.2. Bacterial Diseases
10.2. Market Analysis, Insights and Forecast – By Distribution Channel
10.2.1. Hospital Pharmacies
10.2.2. Retail Pharmacies
10.2.3. Online Pharmacies
10.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
11. Middle East & Africa Pharmaceuticals Market Analysis, Insights and Forecast, 2018-2029
11.1. Market Analysis, Insights and Forecast – By Type
11.1.1. Drugs
11.1.1.1. Oncology
11.1.1.2. Diabetes
11.1.1.3. Infectious Diseases
11.1.1.4. Cardiology
11.1.1.5. Neurology
11.1.1.6. Respiratory
11.1.1.7. Hypertension
11.1.1.8. Others
11.1.2. Vaccines
11.1.2.1. Viral Diseases
11.1.2.2. Bacterial Diseases
11.2. Market Analysis, Insights and Forecast – By Distribution Channel
11.2.1. Hospital Pharmacies
11.2.2. Retail Pharmacies
11.2.3. Online Pharmacies
11.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
11.3.1. GCC
11.3.2. South Africa
11.3.3. Rest of Middle East & Africa
12. Competitive Analysis
12.1. Key Industry Developments
12.2. Global Market Share Analysis (2021)
12.3. Profiles of Players Operating in the Market (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
12.3.1. AstraZeneca
12.3.1.1. Overview,
12.3.1.2. Products,
12.3.1.3. SWOT Analysis,
12.3.1.4. Recent Developments,
12.3.1.5. Strategies,
12.3.1.6. financials (based on availability)
12.3.2. F. Hoffmann-La Roche Ltd.
12.3.2.1. Overview,
12.3.2.2. Products,
12.3.2.3. SWOT Analysis,
12.3.2.4. Recent Developments,
12.3.2.5. Strategies,
12.3.2.6. financials (based on availability)
12.3.3. GlaxoSmithKline plc
12.3.3.1. Overview,
12.3.3.2. Products,
12.3.3.3. SWOT Analysis,
12.3.3.4. Recent Developments,
12.3.3.5. Strategies,
12.3.3.6. financials (based on availability)
12.3.4. Johnson & Johnson Services Inc.
12.3.4.1. Overview,
12.3.4.2. Products,
12.3.4.3. SWOT Analysis,
12.3.4.4. Recent Developments,
12.3.4.5. Strategies,
12.3.4.6. financials (based on availability)
12.3.5. Merck & Co., Inc.
12.3.5.1. Overview,
12.3.5.2. Products,
12.3.5.3. SWOT Analysis,
12.3.5.4. Recent Developments,
12.3.5.5. Strategies,
12.3.5.6. financials (based on availability)
12.3.6. Novo Nordisk A/S
12.3.6.1. Overview,
12.3.6.2. Products,
12.3.6.3. SWOT Analysis,
12.3.6.4. Recent Developments,
12.3.6.5. Strategies,
12.3.6.6. financials (based on availability)
12.3.7. Novartis AG
12.3.7.1. Overview,
12.3.7.2. Products,
12.3.7.3. SWOT Analysis,
12.3.7.4. Recent Developments,
12.3.7.5. Strategies,
12.3.7.6. financials (based on availability)
12.3.8. Pfizer Inc.
12.3.8.1. Overview,
12.3.8.2. Products,
12.3.8.3. SWOT Analysis,
12.3.8.4. Recent Developments,
12.3.8.5. Strategies,
12.3.8.6. financials (based on availability)
12.3.9. Sanofi
12.3.9.1. Overview,
12.3.9.2. Products,
12.3.9.3. SWOT Analysis,
12.3.9.4. Recent Developments,
12.3.9.5. Strategies,
12.3.9.6. financials (based on availability)
13. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings